Synopsis
0
EU WC
0
VMF
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] JDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]KDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]South Africa
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
80
PharmaCompass offers a list of Dydrogesterone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dydrogesterone manufacturer or Dydrogesterone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dydrogesterone manufacturer or Dydrogesterone supplier.
PharmaCompass also assists you with knowing the Dydrogesterone API Price utilized in the formulation of products. Dydrogesterone API Price is not always fixed or binding as the Dydrogesterone Price is obtained through a variety of data sources. The Dydrogesterone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Duvaron manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Duvaron, including repackagers and relabelers. The FDA regulates Duvaron manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Duvaron API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Duvaron manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Duvaron supplier is an individual or a company that provides Duvaron active pharmaceutical ingredient (API) or Duvaron finished formulations upon request. The Duvaron suppliers may include Duvaron API manufacturers, exporters, distributors and traders.
click here to find a list of Duvaron suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Duvaron DMF (Drug Master File) is a document detailing the whole manufacturing process of Duvaron active pharmaceutical ingredient (API) in detail. Different forms of Duvaron DMFs exist exist since differing nations have different regulations, such as Duvaron USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Duvaron DMF submitted to regulatory agencies in the US is known as a USDMF. Duvaron USDMF includes data on Duvaron's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Duvaron USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Duvaron suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Duvaron Drug Master File in Japan (Duvaron JDMF) empowers Duvaron API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Duvaron JDMF during the approval evaluation for pharmaceutical products. At the time of Duvaron JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Duvaron suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Duvaron Drug Master File in Korea (Duvaron KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Duvaron. The MFDS reviews the Duvaron KDMF as part of the drug registration process and uses the information provided in the Duvaron KDMF to evaluate the safety and efficacy of the drug.
After submitting a Duvaron KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Duvaron API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Duvaron suppliers with KDMF on PharmaCompass.
A Duvaron CEP of the European Pharmacopoeia monograph is often referred to as a Duvaron Certificate of Suitability (COS). The purpose of a Duvaron CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Duvaron EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Duvaron to their clients by showing that a Duvaron CEP has been issued for it. The manufacturer submits a Duvaron CEP (COS) as part of the market authorization procedure, and it takes on the role of a Duvaron CEP holder for the record. Additionally, the data presented in the Duvaron CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Duvaron DMF.
A Duvaron CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Duvaron CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Duvaron suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Duvaron as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Duvaron API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Duvaron as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Duvaron and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Duvaron NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Duvaron suppliers with NDC on PharmaCompass.
Duvaron Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Duvaron GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Duvaron GMP manufacturer or Duvaron GMP API supplier for your needs.
A Duvaron CoA (Certificate of Analysis) is a formal document that attests to Duvaron's compliance with Duvaron specifications and serves as a tool for batch-level quality control.
Duvaron CoA mostly includes findings from lab analyses of a specific batch. For each Duvaron CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Duvaron may be tested according to a variety of international standards, such as European Pharmacopoeia (Duvaron EP), Duvaron JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Duvaron USP).
